[2] Palmer D.C., Venkatraman S., Lowe D., Levin J.L., Laakso L.M., Gribble G.W., "
The Chemistry of Heterocyclic Compounds, Oxazoles: Synthesis, Reactions, and Spectroscopy, Part A", John Wiley & Sons Inc., N.J. Hoboken (2004).
[37] Reddy M.R., Reddy G.N., Mehmood U., Hussein I.A., Rahman S.U., Harrabi K., Reddy B.V.S.,
Copper (II) Triflate Catalyzed Synthesis of 2,4-Disubstituted Oxazoles from α-Diazoketones,
Synthesis,
47(21): 3315-3320 (2015).
[46] Tanaka A., Hattori K., Taniguchi K., Okitsu O., Tabuchi S., Nishio M., Nagakura Y., Maeda N., Murai H., Seki J.,
Replacing the Cyclohexene-linker of FR181157 Leading to Novel IP Receptor Agonists: Orally Active Prostacyclin Mimetics. Part 6,
Bioorg. Med. Chem. Lett.,
16(18): 4861-4864 (2006).
[47] Meanwell N.A., Rosenfeld M.J., Wright J.J.K., Brassard C.L., Buchanan J.O., Federici M.E., Fleming J.S., Gamberdella M., Hartl K.S., Zavoico G.B., Seilerf S.M.,
Nonprostanoid Prostacyclin Mimetics. 4. Derivatives of 2-[3-[2-(4,5-Diphenyl-2-oxazolyl)ethyl] phenoxy]acetic Acid Substituted α to the Oxazole Ring, J. Med. Chem.,
36(24): 3871-3883 (1993).
[48] Shibata K., Hanafi M., Fujii J., Sakanaka O., Iinuma K., Ueki M., Taniguchi M.,
UK-2A, B, C and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 III. Absolute Configuration of an Antifungal Antibiotic, UK-2A, and Consideration of Its Conformation, J. Antibiot., 51(12): 1113-1116 (1998).